Early research (Phase 1)Ended earlyNCT04893551
What this trial is testing
Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants
Who this might be right for
Ovarian Neoplasms
BerGenBio ASA 16
Showing 20 of 0 results